Insulin resistance and high sensitivity C-reactive protein in migraine

Canadian Journal of Neurological Sciences

Volumn 35, Issue 4, 2008, Pages 448-451

  Guldiken, Baburhan ^a   Guldiken, Sibel ^a   Demir, Muzaffer ^a   Turgut, Nilda ^a   Kabayel, Levent ^b   Ozkan, Hulya ^b   Ozcelik, Emine ^b   Tugrul, Armagan ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b Social Security Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FEMALE; HOMEOSTASIS; HUMAN; INSULIN METABOLISM; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 55049089972     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100009100     Document Type: Article

References (29)

1. Lauritzen M. Cerebral blood flow in migraine and cortical spreading depression. Acta Neurol Scand. 1987; 113 Suppl: 1-40.
2. Welch KM. Contemporary concepts of migraine pathogenesis. Neurology. 2003; 61 Suppl 4: 2-8.
3. Liew G, Wang JJ, Mitchell P. Migraine and coronary heart disease mortality: a prospective cohort study. Cephalalgia. 2007; 4: 368-71.
4. Kurth T, Gaziano JM, Cook NR, Bubes V, Logroscino G, Diener HC, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med. 2007; 167: 795-801.
5. Agostoni E, Fumagalli L, Santoro P, Ferrarese C. Migraine and stroke. Neurol Sci. 2004; 25 Suppl 3: 123-5.
6. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology. 2005; 64: 614-20.
7. Horev A, Wirguin I, Lantsberg L, Ifergane G. A high incidence of migraine with aura among morbidly obese women. Headache. 2005; 45: 936-8.
8. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006; 67: 252-7.
9. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006; 66: 545-50.
10. Mclaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 2002; 106: 2908-12.
11. Adam FM, Nara MG, Adam JM. Fasting insulin, adiponectin, hs-CRP levels, and the components of metabolic syndrome. Acta Med Indones. 2006; 38: 179-84.
12. Headache Classification Sub-Committee of the International Headache Society. International classification of headache disorders. 2nd ed. Cephalalgia. 2004; 24: 1-160.
13. World Health Organization. Obesity: preventing and managing in global epidemic. Report of a WHO consultation on obesity. Geneva; June, 1997.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-9.
15. Rainero I, Limone P, Ferrero M, Valfre W, Pelissetto C, Rubino E, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia. 2005; 25: 593-7.
16. Yudkin JS. Insulin resistance and the metabolic syndrome-or the pitfalls of epidemiology. Diabetologia. 2007; 50: 1576-86.
17. Chan JC, Tong PC, Critchley JA. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Semin Vasc Med. 2002; 2: 45-57.
18. Mezei Z, Kis B, Geese A, Tajti J, Boda B, Telegdy G, et al. Platelet arachidonate cascade of migraineurs in the interictal phase. Platelets. 2000; 11: 222-5.
19. Crassard I, Conard J, Bousser MG. Migraine and homeostasis. Cephalalgia. 2001; 21: 630-6.
20. Tietjen GE, Al-qasmi MM, Athanas K, Dafer RM, Khuder SA. Increased von Willebrand factor in migraine. Neurology. 2001; 57: 334-6.
21. Cavestro C, Rosatello A, Micca G, Ravotto M, Marino MP, Asteggiano G, et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache. 2007; 47: 1436-42.
22. Kim C, Siscovick DS, Sidney S, Lewis CE, Kiefe CI, Koepsell TD. The CARDIA study. Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: coronary artery risk development in young adults. Diabetes Care. 2002; 25: 1027-32.
23. Drummond PD, Lance JW. Neurovascular disturbances in headache patients. Clin Exp Neurol. 1984; 20: 93-9.
24. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992; 12: 221-8.
25. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke. 2005; 36: 1316-29.
26. Shlipak MG, Ix JH, Bibbins-Domingo K, Lin F, Whooley MA. Biomarkers to predict recurrent cardiovascular disease: the heart and soul study. Am J Med. 2008; 121: 50-7.
27. Welch KM, Brandes AW, Salerno L, Brandes JL. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache. 2006; 46: 197-9.
28. Vanmolkot FH, de Hoon JN. Increased C-reactive protein in young adult patients with migraine. Cephalalgia. 2007; 27; 843-6.
29. Sjaastad O, Bakketeig LS. Migraine without aura: comparison with cervicogenic headache. Vågå study of headache epidemiology. Acta Neurol Scand. 2007 Nov 20.